A multilevel study of MIF in severe Depression (MDD) patients revealed that after three weeks of treatment, patients had significantly lower levels of MIF, but there was no strong evidence to support the utility of MIF as a biomarker for the diagnosis or monitoring of MDD.46 The gene discussed is MIF; the disease is depressive symptom measurement.